We are investigating Celgene Corporation (NasdaqGS: CELG) regarding its sale to Bristol-Myers Squibb Company for $50.00 in cash and 1.0 shares of Bristol-Myers for each share of Celgene.
We are investigating Celgene Corporation (NasdaqGS: CELG) regarding its sale to Bristol-Myers Squibb Company for $50.00 in cash and 1.0 shares of Bristol-Myers for each share of Celgene.